Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab' certolizumab pegol: results of a phase II randomized, placebo-controlled trial with a re-treatment extension (Q83634513)
Jump to navigation
Jump to search
scientific article published on 11 June 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab' certolizumab pegol: results of a phase II randomized, placebo-controlled trial with a re-treatment extension |
scientific article published on 11 June 2012 |
Statements
Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab' certolizumab pegol: results of a phase II randomized, placebo-controlled trial with a re-treatment extension (English)
K Reich
J-P Ortonne
A B Gottlieb
I J Terpstra
G Coteur
C Tasset